Ioana Bica, MD

Assistant Professor, Medicine

(617) 414-5417

Biography

Expertise includes: HIV infection; HCV-HIV Coinfection; Complementary and alternative therapies in HIV field.

Other Positions

  • Active Staff Hospital Privileges, Medicine, Boston Medical Center

Education

  • Carol Davila University of Medicine and Pharmacy, MD
  • Colegiul Na?ional Ion Neculce, BA

Publications

  • Published on 5/1/2013

    Jarrett OD, Wanke CA, Ruthazer R, Bica I, Isaac R, Knox TA. Metabolic syndrome predicts all-cause mortality in persons with human immunodeficiency virus. AIDS Patient Care STDS. 2013 May; 27(5):266-71. PMID: 23651103.

    Read at: PubMed
  • Published on 10/15/2007

    McGovern BH, Birch C, Zaman MT, Bica I, Stone D, Quirk JR, Davis B, Zachary K, Basgoz N, Graeme-Cook F, Gandhi RT. Managing symptomatic drug-induced liver injury in HIV-hepatitis C virus-coinfected patients: a role for interferon. Clin Infect Dis. 2007 Nov 15; 45(10):1386-92. PMID: 17968840.

    Read at: PubMed
  • Published on 5/11/2006

    McGovern BH, Wurcel A, Kim AY, Schulze zur Wiesch J, Bica I, Zaman MT, Timm J, Walker BD, Lauer GM. Acute hepatitis C virus infection in incarcerated injection drug users. Clin Infect Dis. 2006 Jun 15; 42(12):1663-70. PMID: 16705568.

    Read at: PubMed
  • Published on 7/1/2005

    McGovern B, Fiore J, Wurcel A, Taglienti P, Bradley M, Galvin S, Libone G, Ramsey J, Molinaro-Gudas V, Drewniak S, Amick C, Andalkar A, Scheft H, Bica I. Delivering therapy for hepatitis C virus infection to incarcerated HIV-seropositive patients. Clin Infect Dis. 2005 Jul 1; 41 Suppl 1:S56-62. PMID: 16265615.

    Read at: PubMed
  • Published on 2/17/2005

    Mangili A, Bica I, Snydman DR, Hamer DH. Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2005 Apr 1; 40(7):1058-60. PMID: 15825002.

    Read at: PubMed
  • Published on 10/13/2003

    Jacobson DL, Bica I, Knox TA, Wanke C, Tchetgen E, Spiegelman D, Silva M, Gorbach S, Wilson IB. Difficulty swallowing and lack of receipt of highly active antiretroviral therapy predict acute weight loss in human immunodeficiency virus disease. Clin Infect Dis. 2003 Nov 15; 37(10):1349-56. PMID: 14583869.

    Read at: PubMed
  • Published on 8/1/2003

    McGovern B, Bica I. Should treatment of hepatitis C in HIV-seropositive and HIV-seronegative patients with hemophilia include induction doses of interferon? Clin Infect Dis. 2003 Aug 1; 37(3):463-4; author reply 464-5. PMID: 12884180.

    Read at: PubMed
  • Published on 2/1/2003

    Bica I, Tang AM, Skinner S, Spiegelman D, Knox T, Gorbach S, Wilson IB. Use of complementary and alternative therapies by patients with human immunodeficiency virus disease in the era of highly active antiretroviral therapy. J Altern Complement Med. 2003 Feb; 9(1):65-76. PMID: 12676036.

    Read at: PubMed
  • Published on 3/1/2002

    McGovern B, Bica I. Risk of HAART therapy in hepatitis C. Hepatology. 2002 Mar; 35(3):730. PMID: 11870393.

    Read at: PubMed
  • Published on 1/23/2001

    Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, Snydman DR. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis. 2001 Feb 1; 32(3):492-7. PMID: 11170959.

    Read at: PubMed

View 1 more publications: View full profile at BUMC

View all profiles